Eledon Pharmaceuticals, Inc. (ELDN)
3.01
+0.03
(+1.01%)
USD |
NASDAQ |
Sep 01, 16:00
3.015
0.00 (0.00%)
After-Hours: 20:00
Eledon Pharmaceuticals Total Long Term Debt (Quarterly) : 0.086M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.086M |
| March 31, 2026 | 0.186M |
| December 31, 2025 | 0.283M |
| September 30, 2025 | 0.376M |
| June 30, 2025 | 0.467M |
| March 31, 2025 | 0.555M |
| December 31, 2024 | 0.64M |
| September 30, 2024 | 0.315M |
| June 30, 2024 | 0.386M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.083M |
| June 30, 2023 | 0.184M |
| March 31, 2023 | 0.284M |
| December 31, 2022 | 0.383M |
| September 30, 2022 | 0.461M |
| June 30, 2022 | 0.299M |
| March 31, 2022 | 0.35M |
| December 31, 2021 | 0.40M |
| September 30, 2021 | 0.045M |
| June 30, 2021 | 0.09M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 164.95M |
| June 30, 2020 | 0.048M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.097M |
| December 31, 2019 | 0.144M |
| September 30, 2019 | 0.191M |
| June 30, 2019 | 0.236M |
| March 31, 2019 | 0.281M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 3.447M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.978B |
| Viking Therapeutics, Inc. | 3.925M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |